Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2023

Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2023   Valmet Oyj’s stock exchange release on February 22, 2024 at 11:00 a.m. EET   Valmet has today, on February 22, 2024, published its Annual Report for 2023 on the company's website at www.valmet.com/annualreport2023. The Annual Report consists of three separate parts: the Annual Review, the Financial Statements and Report of the Board of Directors and the GRI Supplement.   The Annual Review covers Valmet’s operations, strategy, market environment and

Real Advokatbyrå acted as legal advisor for Barings Real Estate in their venture with Innovation Properties regarding the construction of 264 residential units in the greater Stockholm area

Real Advokatbyrå acted as legal advisor for Barings Real Estate in their venture with Innovation Properties regarding the construction of 264 residential units in the greater Stockholm area. The building will have a high sustainability profile with solar panels, wooden structures and will in general be constructed in a green and sustainable way in order to obtain environmental certificates. The constructor is Lindbäcks Bygg. We thank the Barings team for entrusting us and for the great collaboration along the whole process.

Vultus: Toyama's Retailer Network Goes Live on Vultus's New Platform

Vultus AB (publ) announces that Toyama do Brasil Máquinas Ltda's ("Toyama") extensive retail network, encompassing 7,000 stores in Brazil and South America, is going live on Vultus's new platform. Through its retailer network, Toyama will distribute Vultus's analytics service and platform to the agriculture industry. Revenues will initially amount to approximately 1,5 MSEK in fixed fees and will increase with the variable cost per analyzed hectare.Toyama's network will feature a bespoke platform and app, tailored to deliver Vultus's analytics services. These include Nitrogen Prescriptions,

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 42 – 22 FEBRUARY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Finland Calls for Greater International Collaboration in 6G Research and Development

Recognizing the pivotal role that next-generation connectivity will play in driving economic growth through digitalization and sustainability, Finland is calling for public and private actors around the globe to join forces with its research coalition in the realm of 6G development. Finland has been at the forefront of wireless mobile technology for decades, ever since Nokia launched its first mobile phone in 1982. Building on this expertise and the power of interdisciplinary collaboration, Finland has recently laid the foundations for significant 6G development and positioned

Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data on dose linearity and systemic exposure from the first study with fostroxacitabine bralpamide (fostrox) (NCT03781934) will be presented at the European Association for the Study of the Liver (EASL) Liver Cancer Summit on February 23, 2024, in Rotterdam.   The abstract, titled “Population pharmacokinetic modeling of orally administered fostroxacitabine bralpamide (

Arctic Bioscience – Invitation to presentation of Q4 2023 operational update

Arctic Bioscience will publish a Q4 2023 operational update and preliminary full year 2023 financial results on Friday 1[st] of March, at 08:00 CET.The same day at 11:00 CET, the Company will host a webcast to present the results and give an operational update. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Friday 1[st] of March 2024 Time: 11:00 CET Format: Webcast and Q&A Language: English The presentation can be accessed through the Company’s website, or with the link below: Link: https://channel.royalcast.com/

Terveystalo's Annual Report 2023 published

Terveystalo Plc Annual Financial Report 22 February 2024 at 10:15 am EET Terveystalo Plc has today published its Annual Report for the year 2023. The Annual Report 2023 consists of four parts: · Year 2023 presents information on Terveystalo’s business operations, market environment, strategy and value creation. · Sustainability describes Terveystalo’s sustainability efforts and their results. The Sustainability -section for 2023 is prepared with reference to the GRI Standards. · Corporate Governance includes the Corporate Governance Statement, Remuneration Policy and

Project update Vestmanna: Dragon 12 functionality verified and power production performance satisfactory and as projected

After the first two weeks of testing, the Dragon 12 functionality is verified and power production performance is satisfactory and as projected. All core operating functions such as starting, turning with the tidal flow and electricity generation have been successfully verified in its first phase of operation. Given the stable system behaviour, Minesto concludes the technology risks of scale-up have been significantly reduced.The Minesto 1.2 MW tidal powerplant - Dragon 12 - has since installation two weeks ago delivered as expected during its first phase of operation at its grid-connected

Year-end report

The .Group October – December 2023 (KSEK) · Net sales 9 590 (4 534) +112% · Operating result -4 169 (-15 606) · Result for the period before tax -5 624 (-14 990) · Earnings per share before and after dilution -0.34* (-1.22) The Group January – December 2023 (KSEK) · Net sales 28 270 (13 260) +113% · Operating result -31 471 (-57 706) · Result for the period before tax -32 224 (-55 942) · Earnings per share before and after dilution -2.50* (-4.56) * Earnings per share after tax, calculated on the result for the period and number of shares,12 624 171Summary

Veidekke: Shares purchased by employees in 2024 and Exercise of employee share options by Key employees

With reference to the stock exchange notice dated February 19, 2024, primary insider notifications pursuant to the market abuse regulation article 19 are attached. For further information, please contact: Jørgen Wiese Porsmyr, CFO, +47 907 59 058, jorgen-wiese.porsmyr@veidekke.no This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Frode van der Laak wins “Best Researcher Award” from the International Congress for Research Excellence

Oslo - Norway, 22nd February 2024:  In an extraordinary recognition of his pioneering research and innovations, Reltime is proud to announce that our Chief Technology Officer, Frode van der Laak, has been awarded the "Best Researcher of the Year" award from International Congress for Research Excellence (ICRE). This prestigious accolade is in honour of his ground-breaking paper, "Utilize 5G Mobile Handset as DAO and Node in Layer 1 Proof of Authority Blockchain." International Congress for Research Excellence 2024 (ICRE 24) is the renowned International Research Award given to

Q2 Interim Report October - December 2023

About Hamlet BioPharma   Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of cancer and infections. The goal is to help address unmet medical needs in large patient groups, in need of improved cancer treatments or alternatives to antibiotics. The company is leveraging highly innovative scientific discoveries and an extensive IP portfolio, to take these innovative drugs through mechanistic and preclinical phases, through the development of drug production technology to the clinic. Three projects in clinical

Saab receives support order for Norway’s Combat Training Centre

Saab has received an order from the Norwegian Defence Materiel Organisation regarding support, service and maintenance for the Combat Training Centre in Rena. The order value is approximately SEK 190 million and the contract period is 2024-2027.The contract also includes on-site support for four additional training and simulation locations in Norway, as well as at Rena.  “We are pleased to continue our long-term support to the Norwegian Armed Forces’ training systems. With this contract, we ensure that the Norwegian Armed Forces have the required interoperable training capabilities today

Storytel enters a partnership with Dutch telco VodafoneZiggo

Storytel, today announced a distribution partnership agreement with VodafoneZiggo, one of the leading Dutch telecom companies. Through this deal, Vodafone’s 5.5+ million mobile subscribers will be offered access to Storytel’s extensive catalog of audio stories.The agreement with VodafoneZiggo further accelerates Storytel's business in the Netherlands, one of the company’s core markets. It will allow Vodafone’s 5.5+ million mobile subscribers an opportunity to gain access to Storytel’s market-leading audiobook streaming service and its substantial Dutch language catalog featuring the works

Finnish digital neobank opens in Sweden and raises the interest rates on fixed-term deposits to a new level

Press release EMBARGO ON THURSDAY 22 FEBRUARY at 09:00       Saldo Bank, which is starting its operations in Sweden, offers an interest rate of as much as 5% for a year's deposit. “We want to increase fairness in fixed-term deposits,” says Jarkko Mäensivu, the CEO of Saldo Bank.   The digital neobank with a Finnish background, Saldo Bank, will lift the interest rate competition of the fixed-term deposits to a new level in Sweden.   The bank will start operating in Sweden in February and offers interest rates of up to 5% on one year's fixed-term accounts.

Buy Now, Pay Early: 97.4% of Klarna Black Friday purchases paid off on time or early

· Over half (51%) of purchases were paid off early, ahead of their due date, rebutting warnings from media and campaign groups around the dangers of BNPL · In stark contrast, a third of consumers in the UK believed they would be unable to pay off their Christmas credit card bill in full, at a time when they are facing the highest interest rates in 27 years London, 22nd February 2024 – Klarna, the AI-powered global payments provider and shopping assistant, has revealed UK consumers paid off 97.4% of Black Friday orders on time or early, an increase of 2% compared with last year. The

Read original

Global study: 10% reduction in building and construction CO2 emissions possible — lack of policy support slows down progress

A new study by One Click LCA shows that 59% of construction industry professionals expect at least a 10% reduction in construction and manufacturing carbon emissions from using life-cycle assessments. Still, a lack of public policies, insufficient manufacturer environmental data, and limited investor awareness inhibit progress.Helsinki, Finland (22nd February 2024) — Decarbonization tech platform One Click LCA  has launched a new international study about decarbonizing the construction value chain. According to the Construction LCA and Embodied Carbon Experts Outlook

Hunter Group ASA - PDMR notification

Oslo, 22 February 2024 Hunter Group ASA (the "Company", Oslo Børs Ticker: HUNT) has been notified of the following PDMR trades. Lama Global AS, a close associate of Lars Brynildsrud, CFO and PDMR of the Company, has today sold 1,250,000 shares in the Company at an average price of NOK 2.0 per share. After the transaction Mr. Brynildsrud and close associates owns 4,937 shares in the Company. Following the sale, Mr. Brynildsrud will subscribe for a minimum of 2,000,000 shares in the ongoing subsequent offerings. Seal Invest AS, a close associate of Sujoy Seal, COO and PDMR of the

Gotland Alandia Cruises picks Nowhere Networks as supplier of high-speed internet

Gotland Alandia Cruises, jointly owned by Gotlandsbolaget and Viking Line, has chosen Nowhere Networks as supplier of high-speed internet connectivity for its cruise ship Birka GotlandWhen the pure cruise ship Birka Gotland starts its service in March this year the up to 1,800 passengers on cruises between Stockholm-Mariehamn and Stockholm-Mariehamn-Visby will experience not only an extraordinary cruise in the beautiful Swedish and Åland archipelago, with high quality food, spa and entertainment, but also internet connectivity with high-capacity courtesy of Nowhere Networks. ” Nowhere

Annual Report for the fiscal year 2023

Copenhagen, Denmark, 22 February 2024 - Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the Annual Report for the fiscal year of 2023. The Annual Report is available as an attached file to this release and on the Company’s website. Below is a summary of the report."2023 was a busy year for Curasight where we made significant progress on our mission to revolutionize cancer care. Our theranostics approach for improved diagnosis and treatment options for certain cancers was supported by the announcement of preclinical data using our therapeutic platform uTREAT[®]

BioStock: Adjutec applies for phase I start

Norwegian AdjuTec Pharma prepares for clinical trials with its concept for battling antimicrobial resistance. The company recently raised 16 MNOK and sent a clinical trial application to swedish autorities, aming to start phase I this summer. BioStock contacted CEO Bjørn Klem to get an update.Read the full article at biostock.se : https://www.biostock.se/2024/02/adjutec-applies-for-phase-i-start/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Press Release – Oslo, Norway, February 22, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that the international multicenter Phase III clinical study of Cevira[®] (APL-1702), the non-surgical treatment in development for cervical high-grade squamous intraepithelial lesions (HSIL), will be presented for the first time in the form of an oral presentation at the 2024 European Research Organization on Genital Infection and Neoplasia (EUROGIN), held March 13-16 in Stockholm, Sweden:· Oral

There are no items matching the current filter
There are no more items matching the current filter
Back to top